Registered entities
Nanovery Limited
Reg. No. 11695725United Kingdom
Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 36 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Social engagement
Social engagement: 2.5K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include North East Fund, Earlymarket, Europa, Northstar Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 31% |
| Private equity | 1 | 8% |
| Accelerator & incubator | 2 | 15% |
| Other / undisclosed | 6 | 46% |
Recent activity
8 May 2026
Event
Live webinar from Oligonucleotide Therapeutics Society (OTS) and NANOVERY
25 Mar 2026
Event
Bioanalysis of Oligonucleotide Therapeutics via Nucleic Acid Nanorobotic Platform
27 Nov 2025
Milestone